Literature DB >> 18253068

The kinetics and redox state of nitric oxide determine the biological consequences in lung adenocarcinoma.

Brandon G Bentz1, Neal D Hammer, Brett Milash, Slobodanka Klein, David M Burnett, James A Radosevich, G Kenneth Haines.   

Abstract

Few studies have explored the mechanistic basis for the apparent paradoxical effects of nitric oxide and its interrelated redox species (NO(X)) in cancer biology. Our aim was to determine the differential effects of the redox state and kinetics of nitrosative species on the key cancer processes of apoptosis. Therefore, a murine lung adenocarcinoma cell line was exposed to various NO(X) donor compounds differing in redox state and delivery kinetics. DNA strand breaks (DSBs) were measured by the alkaline single-cell gel electrophoresis assay (the COMET assay) and correlated with cell viability by the MTT and soft agar colony assays, while caspase enzymatic activity was measured using an in vitro fluorogenic caspase assay. Finally, cDNA microarrays defined apoptosis-related gene expression alterations resultant from these NO(X) donors. Exogenous NO(X) differentially influences DSBs, and apoptosis-related cell death and expression based on the redox state and kinetics of NO(X) delivery. In our murine lung adenocarcinoma model we have demonstrated differential effects of NO(X) based on the mode of delivery and redox state. These data suggest that the development of NO(X)-based cancer chemotherapy must consider the redox state and kinetics of delivery into their logical design. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253068     DOI: 10.1159/000115526

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  6 in total

1.  Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines.

Authors:  Yaroslav R Yarmolyuk; Benjamin J Vesper; William A Paradise; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-23

2.  Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide.

Authors:  Benjamin J Vesper; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-05-18

3.  Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines.

Authors:  B J Vesper; A Onul; G K Haines; G Tarjan; J Xue; K M Elseth; B Aydogan; M B Altman; J C Roeske; W A Paradise; H De Vitto; J A Radosevich
Journal:  Tumour Biol       Date:  2012-12-14

4.  The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.

Authors:  Anna E Maciag; Harinath Chakrapani; Joseph E Saavedra; Nicole L Morris; Ryan J Holland; Ken M Kosak; Paul J Shami; Lucy M Anderson; Larry K Keefer
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

5.  A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.

Authors:  Madeeha Aqil; Kim M Elseth; Ashok Arjunakani; Philip Nebres; Courtney P Amegashie; Devang H Thanki; Premal B Desai; James A Radosevich
Journal:  Tumour Biol       Date:  2014-12-11

6.  DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide.

Authors:  Berna Demircan; Burcu Yucel; James A Radosevich
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.